NO980420L - Anvendelse av griseofulvin for å inhibere cancervekst - Google Patents

Anvendelse av griseofulvin for å inhibere cancervekst

Info

Publication number
NO980420L
NO980420L NO980420A NO980420A NO980420L NO 980420 L NO980420 L NO 980420L NO 980420 A NO980420 A NO 980420A NO 980420 A NO980420 A NO 980420A NO 980420 L NO980420 L NO 980420L
Authority
NO
Norway
Prior art keywords
griseofulvin
cancer growth
inhibit cancer
potentiators
potentiator
Prior art date
Application number
NO980420A
Other languages
English (en)
Norwegian (no)
Other versions
NO980420D0 (no
Inventor
James Berger Camden
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO980420D0 publication Critical patent/NO980420D0/no
Publication of NO980420L publication Critical patent/NO980420L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO980420A 1995-08-03 1998-01-30 Anvendelse av griseofulvin for å inhibere cancervekst NO980420L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US183995P 1995-08-03 1995-08-03
US67418196A 1996-07-16 1996-07-16
PCT/US1996/012475 WO1997005870A2 (en) 1995-08-03 1996-07-30 Use of griseofulvin for inhibiting the growth of cancers

Publications (2)

Publication Number Publication Date
NO980420D0 NO980420D0 (no) 1998-01-30
NO980420L true NO980420L (no) 1998-04-03

Family

ID=26669547

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980420A NO980420L (no) 1995-08-03 1998-01-30 Anvendelse av griseofulvin for å inhibere cancervekst

Country Status (16)

Country Link
EP (1) EP0841914A2 (xx)
JP (1) JPH11511136A (xx)
KR (1) KR19990036137A (xx)
AR (1) AR003176A1 (xx)
AU (1) AU713031B2 (xx)
BR (1) BR9609920A (xx)
CA (1) CA2228503A1 (xx)
CZ (1) CZ30598A3 (xx)
HU (1) HUP9903506A3 (xx)
IL (1) IL123094A0 (xx)
MX (1) MX9800945A (xx)
NO (1) NO980420L (xx)
PL (1) PL324905A1 (xx)
SK (1) SK14298A3 (xx)
TR (1) TR199800244T2 (xx)
WO (1) WO1997005870A2 (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
DK1098641T3 (en) * 1998-07-27 2016-08-15 St Jude Pharmaceuticals Inc Chemically induced intracellular hyperthermia
DK1616572T3 (da) * 1998-11-09 2010-12-06 Biogen Idec Inc Kimært anti-CD20-antistof, rituxan, til anvendelse i behandling af kronisk lymfatisk leukæmi
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
ATE489080T1 (de) * 2001-06-25 2010-12-15 Ajinomoto Kk Antitumorale mittel
EP2008652A1 (en) * 2007-06-28 2008-12-31 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering
EP2204367A1 (en) * 2008-12-22 2010-07-07 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering

Also Published As

Publication number Publication date
IL123094A0 (en) 1998-09-24
AU6683496A (en) 1997-03-05
JPH11511136A (ja) 1999-09-28
CA2228503A1 (en) 1997-02-20
HUP9903506A3 (en) 2000-07-28
HUP9903506A2 (hu) 2000-06-28
TR199800244T2 (xx) 1998-09-21
MX9800945A (es) 1998-04-30
CZ30598A3 (cs) 1998-06-17
AU713031B2 (en) 1999-11-18
PL324905A1 (en) 1998-06-22
NO980420D0 (no) 1998-01-30
WO1997005870A2 (en) 1997-02-20
KR19990036137A (ko) 1999-05-25
EP0841914A2 (en) 1998-05-20
AR003176A1 (es) 1998-07-08
WO1997005870A3 (en) 1997-04-17
BR9609920A (pt) 1999-07-06
SK14298A3 (en) 1998-09-09

Similar Documents

Publication Publication Date Title
NO980420L (no) Anvendelse av griseofulvin for å inhibere cancervekst
NO974694L (no) Farmasöytisk preparat som inneholder N-fosfonoglycin-derivater for å inhibere vekst av cancer og virus
CA2328368A1 (en) Anti-inflammatory agents
NO943466L (no) Sårheling og behandling av fibrotiske forstyrrelser
PT1161248E (pt) Composição farmacêutica que contém uma fonte de nitrato e um agente acidificante destinada ao tratamento de feridas abertas e queimaduras
ATE103813T1 (de) Topische metronidazol-formulationen und deren verwendung als arzneimittel.
AU9536898A (en) 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the holesterin-ester transfer protein
MY133569A (en) Method of reducing tissue damage associated with non-cardiac ischemia using glycogen phosphorylase inhibitors
AU4385399A (en) Thiophene and furan 2,5-dicarboxamides useful in the treatment of cancer
EP0705098A4 (en) METHOD FOR IMPROVING THE THERAPEUTIC EFFECTIVENESS OF ACTIVE SUBSTANCES FOR TREATING SOLID TUMORS AND OTHER DISEASES
NO974693L (no) Farmasöytisk preparat inneholdende N-klorfenylkarbamater, N-klorfenyltiokarbamater og N-fosfonoglycin-derivater for å inhibere vekst av cancer og virus i pattedyr
AU3902299A (en) Methods of treating microbial infection and therapeutic formulations therefor
NO980473L (no) Anvendelse av flukonazol for å inhibere cancervekst
NO980419L (no) Anvendelse av 1H,2,4-triazol derivater for å inhibere cancervekst
AU563831B2 (en) N-(2-amino-3,5-dibromobenzyl)- trans-4-amino-cyclohexanol derivatives
ES2120962T3 (es) Composicion antivirica.
ATE216892T1 (de) Inhibitor von nebenwirkungen zur krebstherapy
DK0980205T3 (da) Anvendelse af en kombination af TALL-104 celler med adriamycin eller cisplatin i behandlingen af maligniteter
AU3919001A (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers
CA2081911A1 (en) Method and composition for treating psoriasis
WO1992013532A3 (en) Naphthoquinone derivatives for the treatment of chronic inflammation
NO20012569L (no) Anvendelse av aryl-substituerte syklobutylalkylaminer for behandling av urininkontinens
BR0009289A (pt) Uso de inibidores da vasopeptidase para tratar angina pectoris
NO20020751L (no) Kjemisk stabiliserte klorittlösninger for behandling av cancer og andre sykdommer
BR9914196A (pt) Processo de tratamento da perda de cabelo

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application